With the tremendous influx of CBD companies making their way into the market, it can be daunting trying to figure out where to invest your money.
Despite legal challenges and uncertainty, demand has not wavered and CBD companies continue to grow. So, if we’re following the money trail it will inevitably lead us to a few primary companies with strong fundamentals that show no signs of slowing down.
The first one worth mentioning is pharmaceutical producer CV Sciences (otcqb:CVSI) has also seen a boom in business, especially after announcing that Joseph Maroon, MD, FACS, will be the newest addition to their board of directors. The Nevada-based company manufactures, markets, and sells products that either plant-based CBD or synthetic CBD. CV Sciences has seen impressive gains with a 53% increase in revenue just this last quarter. In total, they’re looking at 203% more sales than this time last year.
Canopy Growth (CGC) has also been in the spotlight lately after Constellation Brands decided to add an additional $4 billion to their initial investment in the company. However, the company has seen a steady surge in profits – around 95% growth – from year to year. Canopy has a stronghold in Canada and now Germany, but they’ve also been expanding to other markets such as Australia and Africa.
Finally, we’ll take a look at ChineseInvestors.com (CIIX), a company that provides financial information and real-time market commentary, and also has multiple CBD subsidiaries. Their 2018 fiscal results were notable, with a 41% increase in revenue since 2017 and a 28,859% increase in consumer product sales.
When making any kind of investment it’s important to do some research on the potential companies and the CBD industry as a whole. When investing in cannabis, that comes with its own set of unique challenges since most of these companies are barred from the U.S. Stock Exchange and often trade in OTC Markets. Since this industry is still in its infancy, it can be hard to find any set of standards or source information. But don’t let that discourage you, as stocks are still affordable to purchase and growing exponentially.